Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adeshwar MeditexBOM:543309 66 ROC (Joel Greenblatt) % is 5.31% as of Mar. 2026, which is 53% below its 10-year median of 11.19. GuruFocus rates BOM:543309 with a GF Score™ of 66/100 and a GF Value™ of ₹14.83 (Fairly Valued). The stock has 5 warning signs investors should review. Among 838 Medical Devices & Instruments companies, Adeshwar Meditex ranks better than 51.43% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Adeshwar Meditex's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 5.31%.
The historical rank and industry rank for Adeshwar Meditex's ROC (Joel Greenblatt) % or its related term are showing as below:
BOM:543309'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 5.58 Med: 11.19 Max: 23.21
Current: 5.88
During the past 9 years, Adeshwar Meditex's highest ROC (Joel Greenblatt) % was 23.21%. The lowest was 5.58%. And the median was 11.19%.
BOM:543309's ROC (Joel Greenblatt) % is ranked better than 51.43% of 838
companies
in the Medical Devices & Instruments industry
Industry Median: 4.64
vs BOM:543309: 5.88
Adeshwar Meditex's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -9.20% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Adeshwar Meditex ROC (Joel Greenblatt) % Related Terms
Adeshwar Meditex ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Adeshwar Meditex's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543309 vs ISRG, BDX, RMD: ROC (Joel Greenblatt) % Comparison
For the Medical Instruments & Supplies subindustry, Adeshwar Meditex's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adeshwar Meditex ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adeshwar Meditex's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Adeshwar Meditex's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 5.31% mean?
Adeshwar Meditex (BOM:543309) has a ROC (Joel Greenblatt) % of 5.31% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Adeshwar Meditex and its competitors. This is 53% below median its historical median of 11.19. Over the past decade, Adeshwar Meditex's ROC (Joel Greenblatt) % has ranged from 5.58 to 23.21. According to the industry distribution chart, Adeshwar Meditex ranks #407 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 48.6%.
Is Adeshwar Meditex's ROC (Joel Greenblatt) % too high?
Adeshwar Meditex's current ROC (Joel Greenblatt) % of 5.31% is 53% below median its 10-year median of 11.19. Over the past 10 years, this metric has ranged from a low of 5.58 to a high of 23.21. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.64. Adeshwar Meditex's value of 5.31% is 14.4% above this industry median. Based on the distribution chart, Adeshwar Meditex ranks #407 out of 838 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Adeshwar Meditex has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Adeshwar Meditex's ROC (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Adeshwar Meditex ranks #407 out of 838 companies for ROC (Joel Greenblatt) %. This puts Adeshwar Meditex in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 4.64. Adeshwar Meditex's value of 5.31% is 14.4% above this benchmark. Historically, Adeshwar Meditex's own ROC (Joel Greenblatt) % has ranged from 5.58 to 23.21 over the past decade. While the company's 10-year median is 11.19 vs. the industry median of 4.64, Adeshwar Meditex has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.64, based on 838 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adeshwar Meditex's current ROC (Joel Greenblatt) % of 5.31% is 14.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Adeshwar Meditex and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adeshwar Meditex's current ROC (Joel Greenblatt) % is 5.31%, which is 53% below median its own 10-year median of 11.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adeshwar Meditex stock overvalued right now?
Based on GuruFocus' analysis, Adeshwar Meditex (BOM:543309) is currently considered Fairly Valued. The stock's GF Value™ is ₹14.83, compared to a current price of ₹16.30 — trading 9.9% above its estimated fair value. The current ROC (Joel Greenblatt) % is 5.31%, which is 53% below median its 10-year median of 11.19 and 14.4% above the Medical Devices & Instruments industry median of 4.64. Adeshwar Meditex's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Adeshwar Meditex (BOM:543309), the current ROC (Joel Greenblatt) % is 5.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adeshwar Meditex (BOM:543309) Overvalued in 2026?
Based on GuruFocus' analysis, Adeshwar Meditex stock appears to be overvalued.
The current stock price of ₹16.30 is trading 9.9% above its estimated GF Value™ of ₹14.83.
GuruFocus considers Adeshwar Meditex to be Fairly Valued.
Key valuation signals for BOM:543309:
ROC (Joel Greenblatt) %: 5.31% (53% below median its 10-year median of 11.19)
GF Value™: ₹14.83 vs. price of ₹16.30 (9.9% above fair value)
Industry Position: 14.4% above the Medical Devices & Instruments median (#407 of 838)
No single metric tells the full story. See the BOM:543309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adeshwar Meditex Ltd is engaged in manufacturing surgical dressings and external preparations products such as Sterile surgical wound dressing, Combine dressing, Gauze Dressing and Cotton Products, Medical Bandages and Plaster, Antiseptics / Disinfectants, and others.
66GF Score
Get the complete analysis for BOM:543309
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543309 has been successfully added to your 
